Pelvic fractures affect more than 150,000 people per year in the U.S. Often caused by car accidents or falls, these fractures are among the most serious and technically complex injuries treated by orthopedic trauma surgeons.
In 2012, Genome BC invested in a Proof of Concept project — Minimally Invasive Curved Intramedullary Pelvic Fixation. Led by Dr. Robin Coope at Canada’s Michael Smith Genome Sciences Centre and Dr. Robert Meek at the University of British Columbia’s Department of Orthopaedic Surgery, the project pivoted around “fixation” technology that offered a new method of stabilizing pelvic fractures using faster and less invasive procedures— basically fixing a pelvic fracture inside the bone.
This past week CurvaFix, Inc. completed its oversubscribed Series B private equity financing, totaling $10.75 million. Genome BC’s early investment critical to the success of this company.